Saint Louis, France

Sylvie Chamoin

USPTO Granted Patents = 13 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • St. Louis, FR (2014 - 2016)
  • Saint Louis, FR (2013 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Innovations of Sylvie Chamoin: A Pioneer in Pharmaceutical Compounds**

Introduction

Sylvie Chamoin is an accomplished inventor based in Saint Louis, France. With a remarkable portfolio of 13 patents, she has significantly contributed to the field of pharmacology. Her innovative work focuses on developing compounds that address critical medical issues, particularly through selective inhibitors.

Latest Patents

Chamoin's recent patents showcase her expertise in designing targeted treatments. One of her latest inventions includes pyridinone derivatives that serve as selective ALK-2 inhibitors. This patent involves a compound of Formula I, methods for manufacturing the compounds, and their therapeutic uses. Moreover, her invention provides a combination of pharmacologically active agents along with a pharmaceutical composition aimed at enhancing treatment efficacy.

Another notable patent includes dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives. This invention describes compounds suitable for treating disorders mediated by PI3K enzymes. The detailed formula and definitions enhance the understanding of the compounds' potential applications in medicine.

Career Highlights

Sylvie Chamoin has had an impressive career, notably contributing her expertise while working for prestigious companies such as Novartis AG and Irm LLC. Her innovative research and development have positioned her as a key figure in pharmaceutical advancements.

Collaborations

Collaboration plays a vital role in Chamoin's work. She has worked alongside esteemed colleagues, including Pascal Furet and Qi-Ying Hu, allowing for a rich exchange of ideas and expertise. These collaborations have undoubtedly influenced her research and led to significant breakthroughs in her field.

Conclusion

Sylvie Chamoin stands out as an influential inventor in the pharmaceutical industry, with her inventions holding promise for advancing medical treatments. Her dedication to innovation and collaboration continues to pave the way for future discoveries, ensuring her legacy in the realm of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…